- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00728962
A Study of Osseotite Certain Prevail Implants Used to Support Short Fixed Bridges With Immediate Occlusal Loading. (Fireball)
A Prospective, Observational Study of Osseotite Certain IOL (Immediate Occlusal Loading) Implants in Immediate Occlusal Loading of Short Span Fixed Restorations
This prospective, multicenter study evaluates the performance of the Osseotite Prevail implant when to support a short fixed bridge with immediate occlusal loading, providing the patient with the use of a temporary prosthesis until the final prosthesis is made.
Study (null) hypothesis: This is an observational study in which no concurrent control group will be observed. Results of the study will be compared with the performance of other Osseotite implants from published Osseotite multicenter studies.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90089
- University of Southern California
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients of either sex and of any race, 18 years of age or older
- patients for whom the decision has already been made to use dental implants for treating partial edentulism in the posterior mandible or maxilla using a short span fixed prosthesis of two to four units
- patients must be physically able to tolerate conventional surgical and restorative procedures
- requirements for implant placement include: at least 1mm bone will be available at the buccal and lingual aspect of the implant and at least 1mm of bone below the apex
- patients must agree to return to the clinic for each study follow-up visit
- requirements for prosthetic fabrication include: bone width at least 6mm and a bone height of at least 11mm
Exclusion Criteria:
- patients with active infection or severe inflammation in the areas intended for implant placement
- patients with a >10 cigarettes / day smoking habit
- patients with uncontrolled diabetes or metabolic bone disease
- patients with a history of therapeutic radiation to the head
- patients in need of bone grafting at the site of the intended study implant; if at the time of surgery some lateral voids need to be filled this is acceptable and does not exclude the patient from the analysis
- patients who are known to be pregnant
- patients with para-functional habits with evidence of severe bruxing or clenching
- placement of implants into sites with less than sixteen weeks of post-extraction healing; for 3-4 unit cases one implant site may have less than sixteen weeks of healing prior to implant placement
- type III or IV bone characteristics of the intended implant sites
- inter-arch distance of less than 7mm (planned location of implant seating platform to the apposing occlusal landmark)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients With Implants Achieving Osseous Integration
Time Frame: 1 year
|
Patients receiving test implant(s) will achieve integration success (implant show no signs of mobility) of the implant at the time of analysis.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Crestal Bone Regression
Time Frame: four years
|
four years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hessam Nowzari, DDS, University of Southern California
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2208
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Partial Edentulism
-
Nobel BiocareCompletedPartial Edentulism | Complete Edentulism
-
Nobel BiocareCompletedPartial Edentulism | Complete Edentulism
-
Sherif Aly SadekGulf Medical UniversityRecruitingComplete Edentulism | Partial Edentulism in the Maxilla or in the Mandible | Partial DentureUnited Arab Emirates
-
Cairo UniversityCompletedPartial-edentulismEgypt
-
ZimVieCompleted
-
D'Albis DentalCompleted
-
Columbia UniversityCompleted
-
Addbio ABCompleted
-
Semmelweis UniversityInstitut Straumann AG; NSK Europe GmbH; Botiss Medical AG; Dicomlab Kft.; Hungarian... and other collaboratorsCompleted
-
Nobel BiocareTerminatedPartial EdentulismGermany